Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia.

Kazutoshi IsobeYasuhiko NakamuraSusumu SakamotoKeisuke TomiiTakayuki TakimotoYasunari MiyazakiMasaru MatsumotoKeishi SuginoKazuya IchikadoShuhei MoriguchiKakuhiro YamaguchiTomohisa Baba Hiroaki OzasaFumiyasu IgataKazuki AnabukiSakae HommaHiroshi DateTakafumi SudaKazuma Kishi

Published in: ERJ open research (2024)

Although ICI treatment was effective for patients with lung cancer with IP, ICIP developed in approximately 30% of patients. Patients with irAEs had a significantly better PFS and OS than those without irAEs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
intensive care unit
combination therapy
mechanical ventilation